MRNA Moderna, Inc.
Healthcare$47.03+0.32%ClosedMarket Cap: $18.66B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.50
P/S
8.36
EV/EBITDA
-6.09
DCF Value
$-1.88
FCF Yield
-8.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
-13.9%
Operating Margin
-153.3%
Net Margin
-143.6%
ROE
-36.7%
ROA
-27.8%
ROIC
-37.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $389.0M | -145.5% | $-1.39B | $-1.34B | $— | — |
| Q4 null | $678.0M | 33.3% | $-857.0M | $-826.0M | $— | — |
| FY null | $1.94B | 55.3% | $-3.07B | $-2.82B | $— | — |
| Q3 null | $1.02B | 0.8% | $-260.0M | $-200.0M | $— | — |
| Q2 null | $142.0M | 16.2% | $-907.0M | $-825.0M | $— | — |
| Q1 null | $107.0M | 15.9% | $-1.05B | $-971.0M | $— | — |
| Q4 null | $956.0M | 22.7% | $-1.25B | $-1.12B | $— | — |
| FY null | $3.20B | 54.2% | $-3.94B | $-3.56B | $— | — |
| Q3 null | $1.85B | 72.3% | $-70.0M | $13.0M | $— | — |
| Q2 null | $221.0M | 48.0% | $-1.36B | $-1.28B | $— | — |
| Q1 null | $167.0M | 42.5% | $-1.27B | $-1.18B | $— | — |
| Q4 2023 | $2.81B | 67.0% | $6.0M | $217.0M | $0.55 | — |